Atossa Therapeutics
ATOS
ATOS
83 hedge funds and large institutions have $17.7M invested in Atossa Therapeutics in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 13 increasing their positions, 23 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
7% less capital invested
Capital invested by funds: $19.1M → $17.7M (-$1.36M)
43% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 23
Holders
83
Holding in Top 10
–
Calls
$174K
Puts
$91K
Top Buyers
| 1 | +$2.47M | |
| 2 | +$1.7M | |
| 3 | +$381K | |
| 4 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$321K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$270K |
Top Sellers
| 1 | -$6.21M | |
| 2 | -$1.28M | |
| 3 | -$1M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$625K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$590K |
